Healthy Habits

Aspirin can be taken daily to reduce the risk of colorectal cancer, but it's not recommended for everyone.

by Bradley Jones

Forward Look

A new way to evaluate patients with prostate cancer.

by Christina Bennett

New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.

by Kendall K. Morgan

People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.

by Kate Yandell

Facts and Stats

New treatments in the U.S. are scrutinized in various ways before and after they are approved by the Food and Drug Administration.

by Bradley Jones

The pandemic has made telehealth a necessity for many cancer patients. When the crisis clears, these technological tools may improve cancer care in the long term.

by Stephen Ornes

From the Editor-in-Chief

Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.

by William G. Nelson, MD, PhD

Forward Look

Despite efforts by policymakers, a gender gap persists in clinical trial participation.

by Lindsey Konkel

Forward Look

Several targeted drugs were approved in 2020 to treat the most common type of lung cancer.

by Ashley P. Taylor

In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?

by Anna Goshua